Why the EU supports health research and innovation
Europe is facing serious healthcare challenges and the COVID-19 pandemic has shown the importance of coordinating health research and innovation among European countries.
These challenges must be met to grant everybody a long and healthy life. Ageing and the increase in chronic diseases like cancer, diabetes, heart disease, and brain conditions that require diverse types of treatment are increasing costs to potentially unsustainable levels, with the risk of unequal access to care for people across the European Union
External environmental factors, including climate change, as well as the risk to lose our ability to protect ourselves against infectious diseases, for instance due to anti-microbial resistance, are also exposing us to new risks and threats.
The European Union is investing in research, technology and innovation to develop solutions to overcome those challenges.
Under Horizon Europe, the EU's current research and innovation funding programme, the main areas of intervention are
- health throughout the life course
- environmental and social health determinants
- non-communicable and rare diseases
- infectious diseases including poverty-related and neglected diseases
- tools, technologies and digital solutions for health and care including personalised medicine
- health care systems
The aim is to find new ways to keep people healthy, prevent diseases, develop better diagnostics and more effective therapies, use personalised medicine approaches to improve healthcare and wellbeing, and take up innovative health technologies, such as digital ones.
Finally, European research and innovation in health is about working together across borders, sharing each other's knowledge and resources and improving our health and care systems together.
Funding opportunities
Funding for health under the research and innovation framework programme, Horizon Europe.
Joint undertaking between the EU and the European Federation of Pharmaceutical Industries and Associations aiming to speed up the up the development of better and safer medicines.
EU4Health, with a budget of €5.3 billion, is the fourth and largest of the EU health programmes since their launch in 2003.
Resource for Small and Medium Enterprises (SMEs) which provides a database of researchers and SMEs in the life-sciences sector and provides advice on all aspects related to EU-funded research projects
Public-public partnership between 14 European and 16 sub-Saharan Africa countries, supported by the European Union.
Projects and results
The Commission's primary portal for results of EU-funded research projects.
Stories of particularly successful EU-funded research projects.
Platform where framework programme funding recipients present their results to search, contact their owners and form partnerships.
Rare Diseases was one of first three P4P pilots showcasing how research and innovation project results shape policy making.
Success stories
The EU-funded AI4LIFE project provides access to AI technologies, making models and AI-ready data sets open and accessible to everyone.
- Project locations
- Finland, France, Germany, Italy, Portugal, Spain, Sweden, United Kingdom
From solar energy beamed from space to genetic brain maps and live self-repairing bridges, research in 2025 is promising.
- Project locations
- Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden
Collaboration and jobs
Look for project partners and view profiles of all organisations that have received funding via the funding and tender opportunities portal.
Researcher jobs in related fields
Candidates and approved partnerships in the health area under the research and innovation funding programme, Horizon Europe.
Partnerships between the Commission and global stakeholders in health.
Virtual networks involving healthcare providers across Europe. They aim to facilitate discussion on complex or rare diseases and conditions that require highly specialised treatment.
Details of health joint programming initiatives which aims to help EU countries pool resources to tackle major challenges for society.
Scientific publications, tools and databases
Interactive reporting platform, composed of a set of sheets that allows series of views to discover and filter the EC's funding programmes data.
The Commission's Joint Research Centre compiles databases and develops software and modelling tools. You can access health related ones here.
Scientific publications produced by the European Commission (JRC)
All scientific publications from Horizon Europe and H2020 are accessible via OpenAIRE.
Single point of access to open data produced by the EU institutions. All data free to use for commercial and non-commercial purposes.
The EU’s total financial contribution under the Africa Initiative I and Work Programme 2022 of GH EDCTP3 JU to African entities amounts to €128 million, engaging a total of 473 African organisations that spanned over 40 African countries.
Latest
Research and innovation news alert: The European Commission has concluded its public consultation on the forthcoming Strategy for European Life Sciences.
Research and innovation news alert: The Commission has launched a call for evidence to gather input for the upcoming Strategy for European Life Sciences.
